NO126388B - - Google Patents
Download PDFInfo
- Publication number
- NO126388B NO126388B NO00168272A NO16827267A NO126388B NO 126388 B NO126388 B NO 126388B NO 00168272 A NO00168272 A NO 00168272A NO 16827267 A NO16827267 A NO 16827267A NO 126388 B NO126388 B NO 126388B
- Authority
- NO
- Norway
- Prior art keywords
- chloral
- derivative
- chloral hydrate
- pentanediol
- methyl
- Prior art date
Links
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 claims description 20
- 229960002327 chloral hydrate Drugs 0.000 claims description 20
- HFFLGKNGCAIQMO-UHFFFAOYSA-N trichloroacetaldehyde Chemical compound ClC(Cl)(Cl)C=O HFFLGKNGCAIQMO-UHFFFAOYSA-N 0.000 claims description 16
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 10
- 229950005499 carbon tetrachloride Drugs 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 230000000622 irritating effect Effects 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 4
- DLHWKJDYXPNWAI-UHFFFAOYSA-N 2,2,2-trichloro-1-ethoxyethanol Chemical compound CCOC(O)C(Cl)(Cl)Cl DLHWKJDYXPNWAI-UHFFFAOYSA-N 0.000 claims description 3
- QVFWZNCVPCJQOP-UHFFFAOYSA-N chloralodol Chemical compound CC(O)(C)CC(C)OC(O)C(Cl)(Cl)Cl QVFWZNCVPCJQOP-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims description 2
- 238000002474 experimental method Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010001580 Albuminuria Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 150000007656 barbituric acids Chemical class 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- -1 for example Chemical compound 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H27/00—Special paper not otherwise provided for, e.g. made by multi-step processes
- D21H27/02—Patterned paper
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04B—GENERAL BUILDING CONSTRUCTIONS; WALLS, e.g. PARTITIONS; ROOFS; FLOORS; CEILINGS; INSULATION OR OTHER PROTECTION OF BUILDINGS
- E04B1/00—Constructions in general; Structures which are not restricted either to walls, e.g. partitions, or floors or ceilings or roofs
- E04B1/62—Insulation or other protection; Elements or use of specified material therefor
- E04B1/625—Sheets or foils allowing passage of water vapor but impervious to liquid water; house wraps
Landscapes
- Engineering & Computer Science (AREA)
- Architecture (AREA)
- Physics & Mathematics (AREA)
- Electromagnetism (AREA)
- Civil Engineering (AREA)
- Structural Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO00168272A NO126388B (fi) | 1967-05-23 | 1967-05-23 | |
| SE06901/68A SE357223B (fi) | 1967-05-23 | 1968-05-21 | |
| FI681435A FI47594C (fi) | 1967-05-23 | 1968-05-22 | Päällystepahvi rakennustarkoituksia varten. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO00168272A NO126388B (fi) | 1967-05-23 | 1967-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO126388B true NO126388B (fi) | 1973-01-29 |
Family
ID=19910075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO00168272A NO126388B (fi) | 1967-05-23 | 1967-05-23 |
Country Status (3)
| Country | Link |
|---|---|
| FI (1) | FI47594C (fi) |
| NO (1) | NO126388B (fi) |
| SE (1) | SE357223B (fi) |
-
1967
- 1967-05-23 NO NO00168272A patent/NO126388B/no unknown
-
1968
- 1968-05-21 SE SE06901/68A patent/SE357223B/xx unknown
- 1968-05-22 FI FI681435A patent/FI47594C/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| FI47594B (fi) | 1973-10-01 |
| SE357223B (fi) | 1973-06-18 |
| FI47594C (fi) | 1974-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO148583B (no) | Kohesive, bare til seg selv og ikke til fremmedlegemer klebende bind for fremstilling av fikseringsbandasjer, og fremgangsmaate til fremstilling av slike bind | |
| WO1999001103A2 (fr) | Derives de peptides, sels de ces derives acceptables sur le plan pharmaceutique, procede de production de ces derives, utilisation de ces derniers et composition pharmaceutique | |
| JPS60166663A (ja) | 新規な３，４，５−トリヒドロキシピペリジン化合物 | |
| TWI224505B (en) | A novel pharmaceutical composition comprising Modafinil and its D/L enantiomers as active components | |
| NO138772B (no) | Fremgangsmaate ved fremstilling av kornorienterte staalplater eller -baand | |
| JPS588044A (ja) | １１−デオキソグリチルレチン酸水素マレ−ト及びそれを有効成分とする医薬 | |
| NO126388B (fi) | ||
| US2931838A (en) | 2-methyl-2-hydroxy-4-(2, 2, 2-trichloro-1-hydroxyethoxy)-pentane and its production | |
| JPS5883620A (ja) | 薬剤としての４−フエニル−４−オキソ−２−ブテン酸のある種の誘導体及びそれを含有する組成物 | |
| Graymore | CCCVI.—The solvent action of trialkyl trimethylenetriamines on uric acid | |
| RU2362575C1 (ru) | Гомеопатические композиции доктора л.в. космодемьянского для лечения и профилактики респираторных воспалительных заболеваний и их осложнений, а также способы их применения | |
| CN114831983A (zh) | 一种褪黑素口腔舌下速溶组合物及其制备方法 | |
| NO148947B (no) | Apparat for paafoering av et flytende bindemiddel. | |
| JPS60501561A (ja) | アゾ−ビス−サリチル酸およびその塩、該酸および該塩の薬学的処方および使用、並びに該酸の製造 | |
| CN111072755A (zh) | 力肽络合物、其药物组合物、其制备方法和应用 | |
| JPH0667880B2 (ja) | ｇｅｍ−ジハロ−１，８−ジアミノ−４−アザ−オクタン類 | |
| CN104497077A (zh) | 色原酮苷类化合物的提取分离方法及在制备镇痛消炎药物中的应用 | |
| CN102408375A (zh) | 奥扎格雷钠化合物 | |
| US4154824A (en) | Nonbitter tasting potassium product for oral administration to warm-blooded animals and method for preparing same | |
| RU2818489C1 (ru) | Комплексное соединение 5-аминосалициловой кислоты с окисленным пектином, проявляющее противоязвенную активность, и способ его получения | |
| CN104971051A (zh) | 一种赛利司他片及制备方法 | |
| US2434625A (en) | Preparation of alkali metal ascorbates | |
| US3156615A (en) | Antacid composition and method of using same | |
| US3591588A (en) | Process for the preparation of 1-carboethoxyhydrazinophthalazine hydrochloride | |
| CN105439889A (zh) | 一种香兰素胺类新化合物、其制备方法及医药用途 |